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pidemiology of Multiple-Resistant Gram-Negative Bacte-
ia in Europe and North America
. Srinivasan
Division of Healthcare Quality Promotion, CDC, Atlanta,
A, USA
ackground: Recent reports of multidrug resistant (MDR)
ram-negative rods (GNR) are concerning; however, it is not
lear how extensive this problem is nationally. The National
ealthcare Safety Network (NHSN) collects information on
elect hospital-associated infections (HAI) from about 600
ospitals throughout the U.S. and is a system that may be
sed to evaluate this problem.
Objectives: To describe the prevalence of MDR among K.
neumoniae, P. aeruginosa or A. baumannii HAIs reported to
HSN.
Methods: HAIs due to the aforementioned pathogens
eported to the NHSN device or procedure modules from
anuary 1, 2006 to September 15, 2007 were evaluated.
solates were included if they had susceptibility results for
t least 1 agent in each of 4 classes of antimicrobials:
minoglycosides, quinolones, beta-lactams (penicillins and
ephalosporins), and carbapenems. Isolates were classiﬁed
s MDR if reported as resistant or intermediate to all drugs
ested in all 4 classes. Other potentially important resis-
ance phenotypes were also evaluated. Pooled mean (%)
DR were determined by pathogen and HAI type. To better
haracterize the national prevalence, results were strati-
ed to control for facilities that reported large numbers of
DR-GNR (outlier facilities).
Results: Overall, 313 hospitals in 42 states reported 4,790
ospital-associated infections with selected GNR: 2,432 P.
eruginosa (bloodstream infection [BSI] 327, ventilator asso-
iated pneumonia [VAP] 889, urinary tract infection [UTI]
66, surgical site infection [SSI] 350); 1,740K. pneumonia
BSI 490, VAP 417, UTI 650, SSI 183); and 791 A. bauman-
ii (BSI 221, VAP 439, UTI 92, SSI 39). Among P. aeruginosa,
% of isolates were MDR and 6% were non-susceptible (NS) to
oth quinolones and aminoglycosides, agents often added to
eta-lactams to treat Pseudomonas. Among K. pneumoniae,
% of isolates were MDR and 10% were NS to carbepen-
ms. Among A. baumannii, 26% were MDR. MDR isolates
ere reported from 68 (30%) facilities in 21 states and
ere more commonly reported from larger hospitals (>500
eds, p < 0.001). The percent isolates that were MDR varied
lightly by type of HAI (table). Pooled mean (%) MDR varied
hen states with outlier facilities were excluded (table).
Conclusions: As deﬁned, MDR among GNR is not rare in US
ospitals reporting data to NHSN. MDR-GNR were not con-
ned to one geographic region and are more common, but
ot limited to, larger hospitals. The paucity of novel antimi-
robial agents in development to treat these organism places
ncreasing emphasis on infection control efforts.
oi:10.1016/j.ijid.2008.05.060
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urden and Future Gram-Negative Resistance in
sia/Australia
.L. Paterson
University of Queensland, Brisbane, Australia
esistance of Gram negative bacilli to commonly used
ntibiotics is commonplace in the Asia-Paciﬁc region. In
eneral, rates of resistance are highest in India and
ome parts of China and lowest in Australia and New
ealand. Extended-spectrum beta-lactamase (ESBL) produc-
ng Klebsiella pneumoniae and Enterobacter cloacae are
igniﬁcant nosocomial pathogens in the region. Rates of
SBL production in some species is as high as 80% in some
nstitutions. Community-onset ESBL producing Escherichia
oli is becoming evident in certain geographic regions such
s Thailand, India and some parts of Australia. CTX-M-
5 has been described in this scenario in India. There
re reports of KPC-producing organisms in China, but thus
ar this resistance mechanism has not been described
lsewhere in Asia/Paciﬁc. Metallo-beta-lactamase produc-
ng Pseudomonas aeruginosa, Acinetobacter baumannii and
nterobacteriaceae are well described in the Asia-Paciﬁc
egion. Carbapenem resistant A. baumannii is a particularly
roblematic pathogen in some ICUs. Signiﬁcant issues with
egards to the high prevalence of antibiotic resistant Gram
egative bacteria in the region include over the counter
vailability of antibiotics in some countries, agricultural use
f antibiotics and suboptimal infection control. Attention to
hese issues is essential to forestall the onset and spread of
olymyxin resistance in the region.
oi:10.1016/j.ijid.2008.05.061
.004
ow to Prevent the Spread of Multiple-Resistant Gram-
egative Bacteria in the Hospital Setting
. Harbarth
Geneva University Hospitals, Geneva, Switzerland
nfections caused by multi-resistant Gram-negative bac-
eria are thought to cause increased morbidity, longer
ength of hospital stay, and higher treatment costs when
ompared to infections caused by susceptible strains. Suc-
essful control of healthcare-associated, multi-resistant
ram-negative bacteria bacteria is relying on several com-
lementary control strategies. Clearly, there is no level
f antibiotic resistance where control measures are not
arranted any more. First, early detection of resistance
arriage may allow rapid contact isolation of identiﬁed car-
iers and improve the adequacy of antibiotic prophylaxis
nd treatment, especially in critically ill patients. Sev-
ral recent outbreak reports have shown the importance
f surveillance and screening cultures in order to prevent
ransmission and infection by multi-resistant Gram-negative
acteria in the critical care setting. Although the most
fﬁcient screening strategy depends on the local situation
nd type of resistance and is therefore still a matter of
ebate, most affected acute care hospitals should install
screening policy for patient groups at high risk of carriage
